| Revenue growth | 26% YoY Consolidated |
|---|---|
| Margins | Insurance Combined Ratio improved 30 bps to 102.7% |
| Demand visibility | Strong retail health insurance growth of 45% |
Growth
Revenue grew 26% YoY. Care Health GWP rose 37% to Rs. 3,247 Cr. Broking PAT grew 65% to Rs. 7.5 Cr.
Outlook
Planned Rs. 250 Cr capital infusion for RHDFCL; scaling up MSME lending in RFL; digital-first transformation across all business verticals.
Risks
Consolidated PAT loss of Rs. 46.9 Cr; RBI communication regarding demerger requires further clarifications; Housing finance GNPA at 4.4%.
Last quarter's promises, checked
Delivered
- Guided Care GWP growth > industry → delivered 37% vs 20% industry (= BEAT)
- Guided RFL to be debt-free → delivered RFL balance sheet entirely debt-free (= BEAT)
- Guided Care combined ratio improvement → delivered 101.4% vs 102.6% prev (= BEAT)
Partly delivered
- Guided demerger scheme implementation → delivered RBI request for further clarifications (= PARTIAL)
Missed
- Guided Care PBT INR 539 Cr (FY26) → delivered Q1 FY27 consolidated loss INR 46.9 Cr (= MISS)
Investor Presentation filed with BSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹225.00
- Market cap
- ₹7,757 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 334.4×Sector 21.9×
- Promoter holding
- 30.56%+0.29% QoQ
- FII holding
- 9.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Annual General Meeting
Religare Enterprises Limited held its 42nd Annual General Meeting on September 24, 2026, where members adopted financial statements and approved the re-designation of Mr. Arjun Lamba.
Religare Enterprises Debt & Borrowing: ₹100 Cr
Religare Enterprises' subsidiary, Care Health Insurance Limited, has allotted non-convertible debentures aggregating to ₹100 Crore. These securities will be listed on the NSE.
- Value
- ₹100.0 Cr
Religare Enterprises Other Announcement
Religare Enterprises Limited has approved the continuation of Mr. Rajender Mohan Malla as the Non-Executive Chairperson for the quarter ending December 31, 2026.
Religare Enterprises Legal & Regulatory
Religare Enterprises informed that the Securities Appellate Tribunal dismissed its appeal against an earlier SEBI order. The company is sharing this legal update for record.
Religare Enterprises Credit Rating
India Ratings affirmed the existing credit rating and assigned a new subordinated debt rating of IND AA-/Stable to Care Health Insurance, a material subsidiary of Religare.
Religare Enterprises Annual General Meeting
Religare Enterprises Limited has scheduled its 42nd Annual General Meeting for September 24, 2026, to be held via Video Conferencing.